Lorenzo D’Angelo was interviewed in PharmaPhorum regarding the challenges companies face in getting digital health technologies (DHT) reimbursed. Lorenzo discusses dedicated pathways for digital health, evidence of patient value, payer value drivers, and how COVID-19 could act as a catalyst for national and local reimbursement systems to start tackling this issue.
The article also draws on CRA’s recent analysis entitled “Challenges and solutions to bringing digital health technologies to market”, which explores the major access and regulatory barriers facing companies attempting to launch DHTs and how the industry can overcome these challenges and work with payers to make access pathways easier to navigate.
